Associated tags: Privacy, Research, Pharmaceutical industry, Health, Patient, Medical device, Nursing
Locations: EUROPE, ISRAEL, SWITZERLAND, AUSTRIA, GERMANY, CANADA, UNITED STATES
BEER-SHEVA, Israel, March 5, 2024 /PRNewswire/ -- MDClone, a leading analytics and synthetic data company, announced today that it has partnered with the University of Chicago and UChicago Medicine to establish an ADAMS Center, a unified data-driven epicenter for innovation, research, and quality improvement projects for the health system.
Key Points:
- Partnership to establish ADAMS Center, enabling University to drive synergy, collaboration, and quicker insights across care and research teams.
- ADAMS represents the innovation process of Ask, Discover, Act, Measure, and then Share, focused on generating quicker insights at scale by fostering synergy among teams.
- MDClone is able to convert the data into reliable synthetic data to protect sensitive health information.
- It will empower clinical teams to lead meaningful change to care delivery and to streamline research and quality improvement activity," said Tom Spiegel, MD, Chief Quality Officer for the UChicago Medicine health system.
Retrieved on:
Tuesday, February 13, 2024
Senior,
USB,
Patient,
Clinical trial,
Privacy,
International business,
Linearity,
Research,
University Hospital of Basel,
Partnership,
Nursing BEER-SHEVA, Israel, Feb. 13, 2024 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced today that it has established a partnership with the University Hospital Basel and a leading life sciences organization to build an infrastructure that will evolve how life sciences and pharma research is performed in the region.
Key Points:
- BEER-SHEVA, Israel, Feb. 13, 2024 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced today that it has established a partnership with the University Hospital Basel and a leading life sciences organization to build an infrastructure that will evolve how life sciences and pharma research is performed in the region.
- USB and its life science partner are implementing MDClone's ADAMS Platform, which enables researchers to analyze health outcomes from large multi-source data sets while maintaining key privacy requirements through synthetic data capabilities.
- Synthetic data is artificially created information that replicates the characteristics and correlations of real patient populations without jeopardizing patient privacy.
- "We're on a mission to expand our horizons globally and form meaningful partnerships with elite institutions like Personalized Health Basel," said Davidi Bachrach, Senior Vice President of International Business at MDClone.
Retrieved on:
Thursday, October 5, 2023
HIV disease progression rates,
HIMSS,
Death,
COPD,
Intermountain Health,
MD,
Population health,
CKD,
Disease,
Dialysis,
Medicare,
Chronic kidney disease,
Information technology,
Chronic obstructive pulmonary disease,
Kidney disease,
Privacy,
Patient,
Pharmaceutical industry,
Nursing,
Medical device,
Intermountain BEER-SHEVA, Israel, Oct. 5, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, extends its congratulations to Intermountain Health for recently being named a 2023 HIMSS Davies Award of Excellence recipient.
Key Points:
- BEER-SHEVA, Israel, Oct. 5, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, extends its congratulations to Intermountain Health for recently being named a 2023 HIMSS Davies Award of Excellence recipient.
- With early identification, Intermountain was able to initiate proactive care management and deploy high-value therapy to improve disease management for patients.
- The HIMSS Davies Award of Excellence showcases healthcare organizations that demonstrate globally innovative, thoughtful applications of information technology to drive and redefine evidence-based best practices so that others can learn, adapt, and improve population health and patient outcomes.
- To learn more about the Intermountain Healthcare - MD MDClone collaboration, please visit https://www.mdclone.com/intermountain-healthcare
Retrieved on:
Wednesday, August 2, 2023
Connect,
Global Network for Advanced Management,
Global Television Network,
Intermountain Health,
Heart,
The Ottawa Hospital,
Research,
Privacy,
Organization,
Patient,
Sheba Medical Center,
Pharmaceutical industry BEER-SHEVA, Israel, Aug. 2, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced today that in the last year it has established partnerships with multiple life sciences organizations to accelerate research and discovery processes through dynamic data exploration.
Key Points:
- BEER-SHEVA, Israel, Aug. 2, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced today that in the last year it has established partnerships with multiple life sciences organizations to accelerate research and discovery processes through dynamic data exploration.
- Via its Connect Platform, MDClone connects life science organizations to rich patient data needed to test hypotheses, build models, validate studies, develop clinical trials, improve care optimization, and create life-saving therapies.
- MDClone helps life sciences overcome these barriers by providing quick access to robust real-world data sets needed to answer complex healthcare questions.
- To learn more about how MDClone is reinventing life sciences innovation, click here .
BE'ER SHEVA, Israel, May 16, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, today announced that Black Book Research has named MDClone the No. 1 quality, diagnosis, and treatment data platform for health systems in the 2023 Black Book Awards.
Key Points:
- BE'ER SHEVA, Israel, May 16, 2023 /PRNewswire/ -- MDClone , a leading data analytics and synthetic data company, today announced that Black Book Research has named MDClone the No.
- 1 quality, diagnosis, and treatment data platform for health systems in the 2023 Black Book Awards.
- MDClone offers solutions that give its partners throughout the healthcare industry the ability to more easily access and leverage data.
- MDClone is the first company to deliver an innovative, self-service, data analytics environment powering exploration, discovery, and collaboration throughout and among healthcare organizations.
BEER-SHEVA, Israel, May 9, 2023 /PRNewswire/ -- Most healthcare organizations are struggling to leverage data to define clinical best practices, according to a new survey by MDClone, a leading data analytics and synthetic data company. Only 16% of the health leaders participating in the survey rated their organizations' performance above "neutral."
Key Points:
- BEER-SHEVA, Israel, May 9, 2023 /PRNewswire/ -- Most healthcare organizations are struggling to leverage data to define clinical best practices, according to a new survey by MDClone, a leading data analytics and synthetic data company.
- Only 16% of the health leaders participating in the survey rated their organizations' performance above "neutral."
- Additionally, while nearly all respondents (96%) expect an increase in the next three years of data-driven knowledge projects that require data access, most healthcare organizations are not prepared today for this surge in demand.
- To learn more about how MDClone can help your organization better leverage its data to improve clinical performance, please visit www.mdclone.com
Telehealth,
Medical device,
Intermountain Health,
Health care,
The Ottawa Hospital,
Electronic health record,
Global health,
Research,
Privacy,
Washington University in St. Louis,
Jefferson Health,
Patient,
EHR,
Medical data breach,
Risk,
Head,
Sheba Medical Center,
Ecosystem,
Health,
Medtech,
Pharmaceutical industry,
Nursing BE'ER SHEVA, Israel, May 3, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, today announced that it has been named "Best Healthcare Big Data Platform" for the third consecutive year in the 7th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.
Key Points:
- MDClone offers solutions that give users across the healthcare ecosystem the ability to more easily access and leverage data.
- MDClone is the first company to deliver an innovative, self-service, data analytics environment powering exploration, discovery, and collaboration throughout and among healthcare organizations.
- "Valuable insights are buried inside the massive quantities of healthcare data, but accessing healthcare data is difficult, time-consuming, and labor-intensive costing health systems valuable resources, time, and money," said James Johnson, managing director, MedTech Breakthrough.
- Congratulations are in order once again this year to MDClone for being MedTech Breakthrough's 'Best Healthcare Big Data Platform!'
Retrieved on:
Wednesday, April 12, 2023
BEER-SHEVA, Israel, April 12, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced today that its MDClone ADAMS Platform is enabling an increasing number of partnerships between provider organizations and life sciences companies to accelerate therapeutic research and development.
Key Points:
- Via its provider partnerships, MDClone connects life sciences organizations to a secure and controlled platform with embedded synthetic data technology, delivering access to privacy-protected, rich patient data needed to test hypotheses, build models, validate studies, develop clinical trials, improve care optimization, and create life-saving therapies.
- The ADAMS platform allows life sciences companies to integrate seamlessly with healthcare systems from around the world, providing access to large data sets, clinical partnerships, information, and expert care teams.
- For example, these collaborative arrangements are enabling life sciences organizations to:
Validate results against original data to verify conclusions for submission, publication, or patient care.
- "MDClone's ADAMS Platform facilitates seamless provider – life sciences collaboration, research, and innovation to create a fundamentally different approach to unlocking the full value of healthcare data."
Adams,
Head,
Knowledge,
Nursing,
Observation,
Pharmacology,
Adams Center,
Physician,
Patient,
Sheba Medical Center,
Management BEER-SHEVA, Israel, Jan. 30, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced the first ADAMS Center, which was launched at Sheba Medical Center in Israel. The ADAMS Center is a reimagined quality and performance improvement model to drive clinical and operational transformation.
Key Points:
- BEER-SHEVA, Israel, Jan. 30, 2023 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, announced the first ADAMS Center, which was launched at Sheba Medical Center in Israel.
- The ADAMS Center is a reimagined quality and performance improvement model to drive clinical and operational transformation.
- Prof. Yitshak Kreiss, Director General of Sheba Medical Center added, "What our new ADAMS Center has demonstrated is the way a technology can profoundly change an organization's culture.
- Sheba's data is made available to clinical teams through the ADAMS Center via the MDClone Platform, which organizes a wide range of clinical and operational information into one system.
Retrieved on:
Monday, November 14, 2022
Magnet,
Ecosystem,
Jefferson Health,
Children's Health Insurance Program,
National Cancer Registrars Association,
Health Partners Plans,
Environment,
Population,
National Cancer Institute,
Medicaid,
Student,
Organization,
Partnership,
Privacy,
School,
Population health,
University of Virginia Cancer Center,
Education,
Research,
Next,
Patient,
ANCC,
Child,
Thomas Jefferson University,
Friction,
CEO,
Hospital,
Science,
Health information management,
Jefferson College,
Solution,
Pharmaceutical industry,
Medicine PHILADELPHIA, Nov. 14, 2022 /PRNewswire/ -- MDClone, a leading data analytics and synthetic data company, and Thomas Jefferson University and Jefferson Health today announced a partnership in which Jefferson will leverage MDClone's innovative synthetic data platform to accelerate academic research.
Key Points:
- PHILADELPHIA, Nov. 14, 2022 /PRNewswire/ -- MDClone , a leading data analytics and synthetic data company, and Thomas Jefferson University and Jefferson Health today announced a partnership in which Jefferson will leverage MDClone's innovative synthetic data platform to accelerate academic research.
- The MDClone ADAMS Platform is a powerful, self-service data analytics environment that enables healthcare collaboration, research, and innovation.
- By making real-world data easier to access, the ADAMS Platform will help Jefferson researchers reduce the friction points to formulating academic research questions, identifying relevant data, analyzing the data, and producing results.
- Jefferson's clinical arm, Jefferson Health, is an 18-hospital health system based in Philadelphia that is home to nationally ranked experts.
